Metabolic Syndrome, Inflammation, and Cancer

Yong Wu,Yunzhou Dong,Shengzhong Duan,Donghui Zhu,Lin Deng

DOI: https://doi.org/10.1155/2017/6598540

2017-01-01

Mediators of Inflammation

Abstract:[This corrects the article DOI: 10.1155/2017/8259356.].

What problem does this paper attempt to address?

Metabolic Syndrome, Inflammation, and Cancer

Yong Wu,Yunzhou Dong,Sheng‐Zhong Duan,Donghui Zhu,Lin Deng

DOI: https://doi.org/10.1155/2017/8259356

2017-01-01

Mediators of Inflammation

Abstract:Article introducing a special issue discussing the link between the metabolic syndrome and the development and progression of cancer. The role of inflammation in these diseases and identification of new therapeutic targets are of great significance. This special issue contributes original research papers and review articles that motivate the continuous efforts to comprehend the mechanisms, production, and management related to cancers associated with the metabolic syndrome.
The Role of Aberrant Metabolism in Cancer: Insights into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer

Yina Yu,Liang Gong,Jun Ye

DOI: https://doi.org/10.3389/fonc.2020.00942

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:Metabolic syndrome (MetS) is characterized by hyperglycemia, hypertension, dyslipidemia and abdominal obesity. Patients with MetS or other metabolic disorders are more susceptible to cancer development and recurrence and have a worse long-term prognosis. Moreover, the metabolic reprogramming observed in cancer cells has also been described as one of the new hallmarks of cancer. Thus, aberrant metabolism has been proposed as an important risk factor for cancer. Chronic inflammation, reactive oxygen species (ROS), and oncogenic signaling pathways are considered as main potential triggers. Considering the strong association between metabolism and cancer, metabolism-modulating drugs, including metformin and statins, as well as adopting a healthy lifestyle, have been extensively investigated as strategies to combat cancer. Furthermore, strategies that interfere with the metabolic rewiring of cells may also have potent anti-cancer effects. In this article, we provide a comprehensive review of current knowledge on the relationship between aberrant metabolism and cancer and discuss the potential use of metabolism-targeting strategy for the treatment of cancer.
Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan,Yinda Yu,Xiaojian Wang,Ting Zhang

DOI: https://doi.org/10.3389/fimmu.2021.775758

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.583084.].
Metabolic Syndrome And Breast Cancer: Prevalence, Treatment Response, And Prognosis

Shuwen Dong,Zheng Wang,Kunwei Shen,Xiaosong Chen

DOI: https://doi.org/10.3389/fonc.2021.629666

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:Metabolic syndrome is a type of multifactorial metabolic disease with the presence of at least three factors: obesity, diabetes mellitus, low high-density lipoprotein, hypertriglyceridemia, and hypertension. Recent studies have shown that metabolic syndrome and its related components exert a significant impact on the initiation, progression, treatment response, and prognosis of breast cancer. Metabolic abnormalities not only increase the disease risk and aggravate tumor progression but also lead to unfavorable treatment responses and more treatment side effects. Moreover, biochemical reactions caused by the imbalance of these metabolic components affect both the host general state and organ-specific tumor microenvironment, resulting in increased rates of recurrence and mortality. Therefore, this review discusses the recent advances in the association of metabolic syndrome and breast cancer, providing potential novel therapeutic targets and intervention strategies to improve breast cancer outcome.
Corrigendum: Lipid metabolism and tumor immunotherapy

Yue Wang,Zongjin Guo,Adamu Danbala Isah,Shuangwei Chen,Yongfei Ren,Huazhong Cai

DOI: https://doi.org/10.3389/fcell.2024.1349379

IF: 5.5

2024-01-26

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2023.1187989.].

cell biology,developmental biology
New Study Progress on the Relationship between Metabolic Syndrome and Cancer

XU Yi-xin,GU Ping,WANG Jian

DOI: https://doi.org/10.3969/j.issn.1007-9572.2012.32.039

2012-01-01

Chinese General Practice

Abstract:Metabolic syndrome(MS) is characterized by high blood pressure,high blood lipid,high blood glucose and central obesity with insulin resistance as the main characteristic.Many researches on epidemiology indicate that MS is related to many malignant tumors like pancreatic cancer,breast cancer,colorectal cancer,liver cancer,gastric cancer,cervical cancer,prostate cancer and lung cancer.This article summarizes the relationship between MS and tumors as well as related mechanisms.
Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin is a Potential Mechanism: A Case–Control Study in Chinese Women

Yujuan Xiang,Wenzhong Zhou,Xuening Duan,Zhimin Fan,Shu Wang,Shuchen Liu,Liyuan Liu,Fei Wang,Lixiang Yu,Fei Zhou,Shuya Huang,Liang Li,Qiang Zhang,Qinye Fu,Zhongbing Ma,Dezong Gao,Shude Cui,Cuizhi Geng,Xuchen Cao,Zhenlin Yang,Xiang Wang,Hong Liang,Hongchuan Jiang,Haibo Wang,Guolou Li,Qitang Wang,Jianguo Zhang,Feng Jin,Jinhai Tang,Fuguo Tian,Chunmiao Ye,Zhigang Yu

DOI: https://doi.org/10.3389/fendo.2020.00227

IF: 6.055

2020-01-01

Frontiers in Endocrinology

Abstract:[This corrects the article DOI: 10.3389/fendo.2019.00905.].
Corrigendum: Immunological Impact of Intestinal T Cells on Metabolic Diseases

Haiyan Zhou,Liwen Wang,Feng Liu

DOI: https://doi.org/10.3389/fimmu.2021.682376

IF: 7.3

2021-04-14

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.639902.].

immunology
Corrigendum: Effect of Carbon Ion Radiation Induce Bystander Effect on Metastasis of A549 Cells and Metabonomic Correlation Analysis

Zhen Yang,Qiuning Zhang,Hongtao Luo,Lihua Shao,Ruifeng Liu,Yarong Kong,Xueshan Zhao,Yichao Geng,Chengcheng Li,Xiaohu Wang

DOI: https://doi.org/10.3389/fonc.2021.783377

IF: 4.7

2021-10-12

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.601620.].

oncology
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao,Mengdi Zhang,Bin Wang,Long Zhang,Fangfang Zhou,Meiyu Fang

DOI: https://doi.org/10.3389/fonc.2021.745052

IF: 4.7

2021-08-17

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.658552.].

oncology
Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Mingchuang Zhu,Qingpeng Zeng,Tao Fan,Yuanyuan Lei,Feng Wang,Sufei Zheng,Xinfeng Wang,Hui Zeng,Fengwei Tan,Nan Sun,Qi Xue,Jie He

DOI: https://doi.org/10.3389/fimmu.2022.909105

IF: 7.3

2022-05-04

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783495.].

immunology
Corrigendum: Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments

Wentao Tian,Yi Liu,Chenghui Cao,Yue Zeng,Yue Pan,Xiaohan Liu,Yurong Peng,Fang Wu

DOI: https://doi.org/10.3389/fcell.2022.865043

IF: 5.5

2022-03-04

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.777018.].

cell biology,developmental biology
Correction: Corrigendum: Association Between Dioxin and Cancer Incidence and Mortality: a Meta-Analysis

Jinming Xu,Yao Ye,Fang Huang,Hanwen Chen,Han Wu,Jian Huang,Jian Hu,Dajing Xia,Yihua Wu

DOI: https://doi.org/10.1038/srep41665

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Scientific Reports 6: Article number: 38012; published online: 29 November 2016; updated: 10 February 2017. The Acknowledgements section in this Article is incomplete. ‘The work was supported by grants from the National Natural Science Foundation of China (Grant Nos 81400371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Corrigendum: The relationship between heavy metals and metabolic syndrome using machine learning

Jun Yao,Zhilin Du,Fuyue Yang,Ran Duan,Tong Feng

DOI: https://doi.org/10.3389/fpubh.2024.1456139

2024-07-29

Abstract:[This corrects the article DOI: 10.3389/fpubh.2024.1378041.].
Metabolic Biomarkers For Prognostic Prediction Of Pre-Diabetes: Results From A Longitudinal Cohort Study (Vol 7, 6575, 2017)

Hailuan Zeng,Renchao Tong,Wenxin Tong,Qiaoling Yang,Miaoyan Qiu,Aizhen Xiong,Siming Sun,Lili Ding,Hongli Zhang,Li Yang,Jingyan Tian

DOI: https://doi.org/10.1038/s41598-017-06309-6

IF: 4.6

2017-01-01

Scientific Reports

Abstract:A correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.
Correction to: Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action

DOI: https://doi.org/10.1093/toxres/tfae024

2024-02-28

Abstract:[This corrects the article DOI: 10.1093/toxres/tfad060.].
The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer

Tong Liu,Yali Fan,Qingsong Zhang,Yiming Wang,Nan Yao,Mengmeng Song,Qi Zhang,Liying Cao,Chunhua Song,Hanping Shi

DOI: https://doi.org/10.1007/s00011-022-01597-9

IF: 6.986

2022-06-19

Inflammation Research

Abstract:Inflammation and metabolic syndrome (MetS) may act synergistically and possibly accelerate the initiation and progression of colorectal cancer (CRC). We prospectively examined the joint effect of MetS and inflammation on the risk of CRC.

immunology,cell biology
Correction To: Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells Via the Inhibition of STAT3 Signaling and Down-Regulation of Inflammatory Cytokine Expressions

Wei Yan,Bing Tu,Yun-Yun Liu,Ting-Yu Wang,Han Qiao,Zan-Jing Zhai,Hao-Wei Li,Ting-Ting Tang

DOI: https://doi.org/10.1038/s41413-019-0052-0

IF: 12.7

2019-01-01

Bone Research

Abstract:[This corrects the article DOI: 10.4248/BR201304007.].
Corrigendum: Diseases of the musculoskeletal system and connective tissue and risk of breast cancer: mendelian randomization study in European and East Asian populations

Yue-chen Xu,Jian-xiong Wang,Yi-ran Chu,Han Qian,Hong-yan Wang,Fan Wang

DOI: https://doi.org/10.3389/fonc.2023.1254132

IF: 4.7

2023-07-28

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1170119.].

oncology
Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis

Qiu-Li Zhu,Wang-Hong Xu,Meng-Hua Tao

DOI: https://doi.org/10.3390/cancers2020721

2010-01-01

Cancers

Abstract:In spite of its public health importance, our understanding of the mechanisms of breast carcinogenesis and progress is still evolving. The metabolic syndrome (MS) is a constellation of biochemical abnormalities including visceral adiposity, hyperglycemia, hyperinsulinemia, dyslipidemia and high blood pressure. The components of the MS have all been related to late-stage disease and even to a poor prognosis of breast cancer through multiple interacting mechanisms. In this review, we aim to present a summary of recent advances in the understanding of the contribution of the MS to breast cancer with the emphasis on the role of biomarkers of the MS in the prognosis of breast cancer.

Metabolic Syndrome, Inflammation, and Cancer

Metabolic Syndrome, Inflammation, and Cancer

The Role of Aberrant Metabolism in Cancer: Insights into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer

Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Metabolic Syndrome And Breast Cancer: Prevalence, Treatment Response, And Prognosis

Corrigendum: Lipid metabolism and tumor immunotherapy

New Study Progress on the Relationship between Metabolic Syndrome and Cancer

Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin is a Potential Mechanism: A Case–Control Study in Chinese Women

Corrigendum: Immunological Impact of Intestinal T Cells on Metabolic Diseases

Corrigendum: Effect of Carbon Ion Radiation Induce Bystander Effect on Metastasis of A549 Cells and Metabonomic Correlation Analysis

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Corrigendum: Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments

Correction: Corrigendum: Association Between Dioxin and Cancer Incidence and Mortality: a Meta-Analysis

Corrigendum: The relationship between heavy metals and metabolic syndrome using machine learning

Metabolic Biomarkers For Prognostic Prediction Of Pre-Diabetes: Results From A Longitudinal Cohort Study (Vol 7, 6575, 2017)

Correction to: Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action

The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer

Correction To: Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells Via the Inhibition of STAT3 Signaling and Down-Regulation of Inflammatory Cytokine Expressions

Corrigendum: Diseases of the musculoskeletal system and connective tissue and risk of breast cancer: mendelian randomization study in European and East Asian populations

Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis